ANAyse Feyda Nursal

Ayse Feyda Nursal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ayse Feyda Nursal has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploring the Role of Leukocyte Telomere Length and Human Telomerase Reverse Transcriptase MNS16A Variant in Cannabis or Synthetic Cannabinoid Use Disorder

    by Sacide Pehlivan, Ayse Feyda Nursal, Hasan Mervan Aytac, Yasemin Oyaci, Eren Aytac, Mustafa Pehlivan

    Sacide Pehlivan, Ayse Feyda Nursal, Hasan Mervan Aytac, Yasemin Oyaci, Eren Aytac, Mustafa Pehlivan. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.25.1389


  • Open Access

    Lack of association between the −2549 insertion/deletion variant of vascular endothelial growth factor and coronary artery disease in the Turkish population

    by Serbulent Yigit, Ayse Feyda Nursal, Atac Celik, Recai Aci, Elgiz Askeroglu

    Coronary artery disease is the leading cause of death worldwide. Vascular endothelial growth factor is known to induce endothelial cell migration and proliferation, increase vascular permeability, and modulate thrombogenicity. The aim of this study is to investigate the relationship between the VEGF insertion/deletion (I/D) variant (rs35569394) and coronary artery disease susceptibility in the Turkish population.


  • miR-146a rs2910164 (G/C) variant may predict morbid obesity risk in adults

    by Zeki Ozsoy, Ayse Feyda Nursal, Seyma Ozsoy, Akin Tekcan, Serbulent Yigit

    Obesity is a common public health problem associated with serious, life-threatening complications. MicroRNAs (miRs) have modulating roles in the immune and inflammatory systems. Therefore, this study aimed to analyze the relationship between miR-146a and morbid obesity (MO) in a Turkish population. In this study, a total of 258 subjects (110 patients with MO and 148 controls) were genotyped by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to analyze miR-146a rs2910164. Then, we examined the patients as males and females separately. The results of the analyses were evaluated for statistical significance. There was a significant difference in genotype and allele frequencies of miR-146a rs2910164 between patients with MO and control individuals. miR-146a rs2910164 CC genotype and C allele were shown to increase in the MO patients' group compared to the control group (p = 0.000, p = 0.000, respectively). Also, the C allele was higher in both female and male patients compared to controls (p = 0.000, p = 0.000, respectively). High differences were also observed when the patients and the controls were compared according to CC versus GG + GC and GG versus GC + CC (p = 0.000, p = 0.000, respectively). A significant difference was found between the female/male patients and the female/male controls in terms of GG + GC versus CC (p = 0.000, p = 0.000, respectively). To the best of our knowledge, this is the first study to investigate the relationship between this variant and MO in Turkey. Our results showed that miR-146a rs2910164 is a valuable biomarker that can be used to distinguish between patients with MO and the healthy population. The findings can be extended by increasing the sample sizes with diverse ethnicities.


  • Relationship of LEP, LEPR Variants, and LEP Methylation with Multiple Myeloma and Prognosis

    by Yasemin Oyacı, Ayşe Feyda Nursal, İstemi Serin, Sacide Pehlivan, Mustafa Pehlivan

  • Open Access

    Genetic association of the BsmI variant of vitamin D receptor gene with risk of morbid obesity

    by Seyma Ozsoy, Serbulent Yigit, Ayse Feyda Nursal, Zeki Ozsoy, Mehmet Fatih Dasiran, Emin Daldal, Akin Tekcan

    The aim of this study was to evaluate the vitamin D receptor (VDR) BsmI variant in morbidly obese patients compared with healthy normal controls.


  • Open Access

    SPERM PARAMETERS' PREDICTIVE VALUE IN INTRAUTERINE INSEMINATION SUCCESS: A SINGLE-CENTER EXPERIENCE

    by Muhamet Afşi̇n, Ayşe Feyda NURSAL, Serap Mutlu Özçeli̇k Otcu, Dilek Yavuz, Serhat Ege

    Although intrauterine insemination is a widely used assisted reproductive technique there is no consensus on sperm parameters that affect the probability of pregnancy. Therefore, the purpose of this study was to determine whether semen parameters affect intrauterine insemination success. A total of 403 couples (345 negative pregnancies, and 58 positive pregnancy) that underwent 549 intrauterine insemination treatment cycles for heterogenous indications were included in the study. Clomiphen citrate, letrazole and/or gonadotropins were used for ovarian stimulation in women in this study. The spermiogram tests of the spouse of receiving IUI tretment were examined. Clinical pregnancy occurred in 58 of 549 intrauterine insemination (10.56%). Unexplained infertility, polycystic ovary syndrome, and cervical-tubal factors were higher in positive pregnancy group compared to negative pregnancy group while male factor was more prevalant in negative pregnancy group comparison to positive pregnancy group (p=0.03). There was no statistical difference between women with positive and negative pregnancy in terms of age (≤ 35 and > 35), body mass index, infertility type, infertility time, endometrial thickness on HCG day, stimulation protocol, cycle numbers, number of insemination, estradiol, prolactin, LH, FSH, and TSH levels (p>0.05). The sperm characteristics in males [ejaculate volum, sperm concentration, total sperm count, motility, immotility, and total progressive motile sperm count] did not significantly differed between positive and negative pregnancy groups (p>0.05). Briefly, the present study found that the conception probability of intrauterine insemination did not correlate with the spermiogram parameters.

  • Open Access

    ESR1 rs2234693 might be associated with TMD risk in the Turkish population, but not rs9340799

    by Ayşe Feyda Nursal, Serbülent Yiğit, Adem Keskin, Mehmet Kemal Tümer

    Aims: The gender and age distribution of temporomandibular disorder (TMD) suggest a possible role for the female hormonal axis in the pathogenesis. The goal of this study was to evaluate if estrogen receptor (ESR1) gene variants contribute to TMD susceptibility in the Turkish population. Methods: A total of 270 people, 130 of whom were TMD patients and 140 healthy controls, were included in the study. The ESR1 PvuII (rs2234693) and Xbal (rs9340799) variants were genotyped using the polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP). The results were evaluated statistically. Results: There were 110 women (81.48%) and 25 men (18.52%) in the patient group. We found there was a significant association between rs2234693 T/C, C/C genotypes and TMD (p=0.007). Also, the C allele was more prevalent in patients compared to controls (p=0.002). A statistically significant association was observed when the patients were compared with the controls according to TT versus TC+CC (p=0.002). There was no statistical significance between the patient and control groups in terms of rs9340799 genotype and allele distribution. Then we evaluated the relationship between genotype distributions and clinical characteristics. Both males and females had the highest rs2234693 T/C genotype (p=0.049). The majority of people with bruxism, bruxomania, and bruxism plus bruxoma carried the rs2234693 T/C genotype (p=0.025). Conclusion: Our results showed that ESR1 rs2234693 might be associated with TMD risk in the Turkish population, but not rs9340799.

  • Lack of association between VNTR variant of the circadian gene (PER3) and major depressive disorder in a sample of a Turkish population

    by Serbulent Yigit, Ayse Feyda Nursal, Filiz Ozsoy, Esra Duman, Melih Sercan Ustaoglu

    Major depressive disorder (MDD), which is a prevalent psychiatric disorder, is characterized by sleep-wake disturbances. An underlying circadian rhythm disorder mainly may cause these disturbances. The study presented here was designed to investigate the existence of Period Circadian Regulator 3 (PER3) gene VNTR variant in MDD patients in Turkish population. A sample of 118 patients with MDD and 150 healthy volunteers were included in the study. The PER3 VNTR genotyping was performed on DNA by polymerase chain reaction (PCR) using specific primers. The prevalence rates of genotypes of 5/5, 5/4, and 4/4 profiles for the PER3 variant were 30.5%, 55.9%, and 13.6%, respectively, in patients with MDD, and 23.3%, 57.3%, and 19.3%, respectively in the control group. No significant difference was observed between the two groups in terms of either genotype distributions or allele frequencies of the VNTR variant of the PER3 gene (p > 0.05). There was no statistically significant association between the patients and the controls in terms of 5/5 + 4/5 versus 4/4 and 5/5 versus 4/5 + 4/4 (p > 0.05). The present results suggest that the PER3 VNTR variant was not associated with MDD in the Turkish population. However, further studies with other gene variants in different ethnic populations are needed to address the exact role of this variant in MDD.

  • Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort study

    by Ozlem Sezer, Ayse Feyda Nursal, Ozgur Gunal, Selim Gorgun, Akin Tekcan, Goksenin Unluguzel Ustun, Serbulent Yigit

    Coronavirus disease 2019 (COVID-19) is a multisystem disease of global significance. Interleukin (IL)-6 is a soluble cytokine with a pleiotropic effect on inflammation and the immune response. Investigate the relationship between the interleukin 6 (IL6) rs1800795 variant and IL6 level in Turkish patients with COVID-19 disease. Prospective cohort study. Tertiary care hospital. Real-time polymerase chain reaction (RT-PCR)-positive and/or chest computerized tomography (CT) scan-compatible COVID-19 patients were enrolled in the study. The clinical data and whole blood samples were collected from April 1, 2020, to August 1, 2020. IL6 rs1800795 genotyping was performed by the PCR-restriction fragment-length polymorphism (RFLP) method in 148 patients. Serum IL-6 concentrations were measured using the ELISA method in 89 patients. We evaluated the patients in three groups: asymptomatic, symptomatic, and intensive care unit patients. IL6 rs1800795 genotype frequencies and serum IL-6 levels in COVID-19 patients with different clinical presentations. 148 cases. IL6 rs1800795 GG genotype and G allele frequency increased in PCR positive patients compared to PCR-negative patients (p ˂ 0.000). IL6 rs1800795 GC genotype and C allele frequency were lower in PCR-positive patients than in PCR-negative patients. IL6 rs1800795 GG genotype and G allele frequency were higher in asymptomatic patients than in the symptomatic and intensive care unit groups. The IL6 rs1800795 C allele frequency was lower in asymptomatic patients than in the symptomatic and intensive care unit groups. IL6 rs1800795 GG genotype and G allele frequency were higher in CT negative patients than CT positive patients, while IL6 GC genotype and C allele frequency were higher in CT positive patients than negative patients. IL6 level elevation was seen in the asymptomatic patients compared to the symptomatic and intensive care unit groups. These findings suggest that IL6 rs1800795 may contribute to the susceptibility of COVID-19 in people to Turkish origin. Further large-scale studies in different genetic populations are needed as this is a single-center, prospective study.


  • Open Access

    Evaluation of the methylation status of the MB-COMT, APC2, NR3C1, and DRD2 genes in Turkish patients with microtia

    by Sacide Pehlivan, Ayşe Feyda Nursal, Yasemin Oyacı, Mustafa Pehlivan, Mehmet Bekerecioğlu

    Aims: Microtia is defined as a congenital malformation of the middle and external ears. DNA methylation is the major epigenetic modification of genomic DNA that is regulated in the early embryonic stage. In this study, we analyzed the methylation status of the MB-COMT, APC2, NR3C1, and DRD2 genes in patients with microtia. Methods: The blood samples were taken from microtia patients and healthy controls. Genomic DNA was isolated using a commercial kit. The methylation status of the MB-COMT, APC2, NR3C1, and DRD2 genes was analyzed using the methylation-specific polymerase chain reaction (MS-PCR) method. The results were evaluated statistically. Results: The DRD2 methylation status was found to be associated with microtia (p?0.001). We found that the DRD2 gene was partially methylated in all patients with microtia. There was no significant difference between the methylation status of the MB-COMT, APC2, and NR3C1 genes and microtia. Conclusion: To our knowledge, this is the first study in our country to evaluate the relationship between the methylation of these genes and the risk of microtia. Our results demonstrate the presence of epigenetic changes in the DRD2 gene during microtia development. Methylation may have contributed to the pathogenesis of microtia as it affects gene expression. Studies with larger sample sizes and in different ethnic groups are needed to further investigate the role of these genes in microtia.